Stephen Caldwell (Rohit Loomba, R Loomba, Rohit C Loomba)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 219

Top Venues

Alimentary pharmacology & therapeutics

The American journal of gastroenterology

Hepatology (Baltimore, Md.)

Gut

University of California San Diego School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California San Diego School of Medicine

United States

Professor of Medicine :: NAFLD Research Center, Department of Medicine

Publications

Cynthia Li-Shin Hsu, Stephen Caldwell
From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research. Nature metabolism 6 (4) (2024)
Stephen Caldwell, Alnoor Ramji, Tarek Hassanein, Eric M Yoshida, Emily Pang, Caitlin Schneider, Michael P Curry, Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatology communications 8 (4) (2024)
Carolin Victoria Schneider, Kai Markus Schneider, Stephen Caldwell
Editorial: Crystalising the burden of steatotic liver disease-Authors' reply. Alimentary pharmacology & therapeutics 59 (10) (2024)
Carolina A Ramírez, Hanna L Blaney, Natalia Kubanek, Luis Antonio Diaz, Stephen Caldwell, Lubomir Skladany, Juan Pablo Arab
Review article: Current indications and selection criteria for early liver transplantation in severe alcohol-associated hepatitis. Alimentary pharmacology & therapeutics 59 (9) (2024)
Nabil Noureddin, Daniel Q Huang, Ricki Bettencourt, Harris Siddiqi, Abdul M Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Hirokazu Takahashi, Ramazan Idilman, Mesut Gumussoy, Digdem Kuru Oz, Ayse Erden, Tolga Gidener, Alina M Allen, Veeral Ajmera, Stephen Caldwell
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease. Alimentary pharmacology & therapeutics 59 (12) (2024)
Stephen Caldwell, Ginger Clark, Jeff Teckman, Veeral H Ajmera, Cynthia Behling, Mark Brantly, David Brenner, Jeanine D'Armiento, Michael W Fried, Janani S Iyer, Mattias Mandorfer, Don C Rockey, Monica A Tincopa, Raj K Vuppalanchi, Zobair M Younossi, Aleksander Krag, Alice M Turner, Pavel Strnad
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease. Alimentary pharmacology & therapeutics 59 (10) (2024)
Stephen Caldwell, Ginger Clark, Jeff Teckman, Veeral H Ajmera, Cynthia Behling, Mark Brantly, David Brenner, Jeanine D'Armiento, Michael W Fried, Janani S Iyer, Mattias Mandorfer, Don C Rockey, Monica A Tincopa, Raj K Vuppalanchi, Zobair M Younossi, Aleksander Krag, Alice M Turner, Pavel Strnad
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease. Alimentary pharmacology & therapeutics 59 (10) (2024)
Stephen Caldwell, Maral Amangurbanova, Ricki Bettencourt, Egbert Madamba, Harris Siddiqi, Lisa Richards, Cynthia Behling, Claude B Sirlin, Mildred D Gottwald, Shibao Feng, Maya Margalit, Daniel Q Huang
MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH. Gut 73 (8) (2024)
Stephen Caldwell, Alnoor Ramji, Tarek Hassanein, Eric M Yoshida, Emily Pang, Caitlin Schneider, Michael P Curry, Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatology communications 8 (4) (2024)
Suzanne R Sharpton, Stephen Caldwell
Reply: Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC. Hepatology (Baltimore, Md.) 80 (1) (2024)
Stephen Caldwell, Maral Amangurbanova, Ricki Bettencourt, Egbert Madamba, Harris Siddiqi, Lisa Richards, Cynthia Behling, Claude B Sirlin, Mildred D Gottwald, Shibao Feng, Maya Margalit, Daniel Q Huang
MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH. Gut 73 (8) (2024)
Stephen Caldwell, Mark L Hartman, Eric J Lawitz, Raj Vuppalanchi, Jérôme Boursier, Elisabetta Bugianesi, Masato Yoneda, Cynthia Behling, Oscar W Cummings, Yuanyuan Tang, Bram Brouwers, Deborah A Robins, Amir Nikooie, Mathijs C Bunck, Axel Haupt, Arun J Sanyal, null null
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis. The New England journal of medicine 391 (4) (2024)
Stephen Caldwell, Alnoor Ramji, Tarek Hassanein, Eric M Yoshida, Emily Pang, Caitlin Schneider, Michael P Curry, Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatology communications 8 (4) (2024)
Elliot B Tapper, David S Goldberg, Neehar D Parikh, Norah A Terrault, Nicole Welch, Suzanne Sharpton, Bilal Hameed, Mandana Khalili, Andrew A Stolz, Elizabeth C Verna, Robert S Brown, Arun J Sanyal, Lisa B Van Wagner, Daniela P Ladner, Cynthia A Moylan, Anna Mae Diehl, Patricia D Jones, Stephen Caldwell, Srinivasan Dasarathy, Douglas A Simonetto, Vijay H Shah, Jasmohan Singh Bajaj, null null
The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints. The American journal of gastroenterology (2024)
Alexander H Yang, Monica A Tincopa, Federica Tavaglione, Veeral H Ajmera, Lisa M Richards, Maral Amangurbanova, Christian Butcher, Christie Hernandez, Egbert Madamba, Seema Singh, Ricki Bettencourt, Bernd Schnabl, Claude B Sirlin, Stephen Caldwell
Prevalence of steatotic liver disease, advanced fibrosis and cirrhosis among community-dwelling overweight and obese individuals in the USA. Gut (2024)
Raj K Vuppalanchi, Stephen Caldwell, Arun J Sanyal, Amir Nikooie, Yuanyuan Tang, Deborah A Robins, Bram Brouwers, Mark L Hartman
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures. Alimentary pharmacology & therapeutics (2024)
Carolina A Ramírez, Hanna L Blaney, Natalia Kubanek, Luis Antonio Diaz, Stephen Caldwell, Lubomir Skladany, Juan Pablo Arab
Review article: Current indications and selection criteria for early liver transplantation in severe alcohol-associated hepatitis. Alimentary pharmacology & therapeutics 59 (9) (2024)
Carolina A Ramírez, Hanna L Blaney, Natalia Kubanek, Luis Antonio Diaz, Stephen Caldwell, Lubomir Skladany, Juan Pablo Arab
Review article: Current indications and selection criteria for early liver transplantation in severe alcohol-associated hepatitis. Alimentary pharmacology & therapeutics (2024)
Cynthia Li-Shin Hsu, Stephen Caldwell
From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research. Nature metabolism 6 (4) (2024)
Maria C Rieman-Klingler, Jinho Jung, Kaleb Tesfai, Stephen Caldwell, Amy L Non
Integrating genetic and socioeconomic data to predict the progression of nonalcoholic fatty liver disease. American journal of biological anthropology (2024)
Carolin Victoria Schneider, Kai Markus Schneider, Anastasia Raptis, Helen Huang, Christian Trautwein, Stephen Caldwell
Prevalence of at-risk MASH, MetALD and alcohol-associated steatotic liver disease in the general population. Alimentary pharmacology & therapeutics 59 (10) (2024)
Lana Bridi, Saaket Agrawal, Kaleb Tesfai, Egbert Madamba, Ricki Bettencourt, Lisa M Richards, Amit V Khera, Stephen Caldwell, Veeral H Ajmera
The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. Alimentary pharmacology & therapeutics (2024)
Wen Hui Lim, Phoebe Tay, Cheng-Han Ng, Darren Jun Hao Tan, Christen Ong, Jia Hong Koh, Margaret Teng, Douglas Chee, Zhen Yu Wong, Takumi Kawaguchi, Hirokazu Takahashi, Mark Dhinesh Muthiah, Eunice X X Tan, Karn Wijarnpreecha, Guan Huei Lee, Mazen Noureddin, Brian P Lee, Philippe Mathurin, Stephen Caldwell, Daniel Q Huang
Meta-analysis: Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis. Alimentary pharmacology & therapeutics 59 (6) (2024)
Richard K Sterling, Eduardo Vilar-Gomez, Laura A Wilson ScM, Stephen Caldwell, Samer Gawrieh, Jennifer Price, Susanna Naggie, Jordan E Lake, Sonya L Heath, James Tonascia, Mark S Sulkowski, Naga Chalasani, null null
Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living with HIV and Steatotic Liver Disease. The American journal of gastroenterology (2024)
Lana Bridi, Saaket Agrawal, Kaleb Tesfai, Egbert Madamba, Ricki Bettencourt, Lisa M Richards, Amit V Khera, Stephen Caldwell, Veeral H Ajmera
The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. Alimentary pharmacology & therapeutics 60 (3) (2024)
Cynthia Li-Shin Hsu, Stephen Caldwell
From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research. Nature metabolism 6 (4) (2024)
Ashwini Mulgaonkar, Daniel Q Huang, Harris Siddiqi, Kathryn J Fowler, Claude B Sirlin, Robert Marks, Stephen Caldwell, Gauree Gupta Konijeti
Cost-Effectiveness Analysis of Hepatocellular Carcinoma Surveillance in Nonalcoholic Fatty Liver Disease Cirrhosis Using US Visualization Score C-Triggered Abbreviated MRI. The American journal of gastroenterology (2024)
Gauree G Konijeti, Stephen Caldwell
Response to Tapper and Chhatwal. The American journal of gastroenterology 119 (6) (2024)
Raj K Vuppalanchi, Stephen Caldwell, Arun J Sanyal, Amir Nikooie, Yuanyuan Tang, Deborah A Robins, Bram Brouwers, Mark L Hartman
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures. Alimentary pharmacology & therapeutics 60 (1) (2024)
Nimish Thakral, Hailemichael Desalegn Mekonnen, Luis Antonio Diaz, Daniel Cabrera, Stephen Caldwell, Marco Arrese, Juan Pablo Arab
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD. Seminars in liver disease (2024)
Maria C Rieman-Klingler, Jinho Jung, Kaleb Tesfai, Stephen Caldwell, Amy L Non
Integrating genetic and socioeconomic data to predict the progression of nonalcoholic fatty liver disease. American journal of biological anthropology 184 (4) (2024)
A Sidney Barritt, Feng Yu, Andrea R Mospan, Philip Noel Newsome, Michael Roden, Heather Lynne Morris, Stephen Caldwell, Brent A Neuschwander-Tetri, null null
High concordance between nonalcoholic fatty liver disease and metabolic dysfunction associated steatotic liver disease in the TARGET-NASH real world cohort. The American journal of gastroenterology (2024)
Stephen Caldwell, Maral Amangurbanova, Ricki Bettencourt, Egbert Madamba, Harris Siddiqi, Lisa Richards, Cynthia Behling, Claude B Sirlin, Mildred D Gottwald, Shibao Feng, Maya Margalit, Daniel Q Huang
MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH. Gut (2024)
Lana Bridi, Saaket Agrawal, Kaleb Tesfai, Egbert Madamba, Ricki Bettencourt, Lisa M Richards, Amit V Khera, Stephen Caldwell, Veeral H Ajmera
The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. Alimentary pharmacology & therapeutics 60 (3) (2024)
Wen Hui Lim, Phoebe Tay, Cheng-Han Ng, Darren Jun Hao Tan, Christen Ong, Jia Hong Koh, Margaret Teng, Douglas Chee, Zhen Yu Wong, Takumi Kawaguchi, Hirokazu Takahashi, Mark Dhinesh Muthiah, Eunice X X Tan, Karn Wijarnpreecha, Guan Huei Lee, Mazen Noureddin, Brian P Lee, Philippe Mathurin, Stephen Caldwell, Daniel Q Huang
Meta-analysis: Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis. Alimentary pharmacology & therapeutics 59 (6) (2024)
Stephen Caldwell, Alnoor Ramji, Tarek Hassanein, Eric M Yoshida, Emily Pang, Caitlin Schneider, Michael P Curry, Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatology communications 8 (4) (2024)
Cynthia Li-Shin Hsu, Stephen Caldwell
From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research. Nature metabolism 6 (4) (2024)
Lana Bridi, Saaket Agrawal, Kaleb Tesfai, Egbert Madamba, Ricki Bettencourt, Lisa M Richards, Amit V Khera, Stephen Caldwell, Veeral H Ajmera
The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. Alimentary pharmacology & therapeutics 60 (3) (2024)
A Sidney Barritt, Feng Yu, Andrea R Mospan, Philip Noel Newsome, Michael Roden, Heather Lynne Morris, Stephen Caldwell, Brent A Neuschwander-Tetri, null null
High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort. The American journal of gastroenterology 119 (8) (2024)
Cynthia Li-Shin Hsu, Stephen Caldwell
From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research. Nature metabolism 6 (4) (2024)
Stephen Caldwell, Mark L Hartman, Eric J Lawitz, Raj Vuppalanchi, Jérôme Boursier, Elisabetta Bugianesi, Masato Yoneda, Cynthia Behling, Oscar W Cummings, Yuanyuan Tang, Bram Brouwers, Deborah A Robins, Amir Nikooie, Mathijs C Bunck, Axel Haupt, Arun J Sanyal, null null
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis. The New England journal of medicine (2024)
Niharika R Samala, Yuchen Xin, Laura A Wilson ScM, Katherine P Yates, Stephen Caldwell, Jay H Hoofnagle, Naga Chalasani, null null
Non-Hispanic Black Persons With Nonalcoholic Fatty Liver Disease Have Lower Rates of Advanced Fibrosis, Cirrhosis, and Liver-Related Events Even After Controlling for Clinical Risk Factors and PNPLA3 Genotype. The American journal of gastroenterology (2024)
Stephen Caldwell, Ginger Clark, Jeff Teckman, Veeral H Ajmera, Cynthia Behling, Mark Brantly, David Brenner, Jeanine D'Armiento, Michael W Fried, Janani S Iyer, Mattias Mandorfer, Don C Rockey, Monica A Tincopa, Raj K Vuppalanchi, Zobair M Younossi, Aleksander Krag, Alice M Turner, Pavel Strnad
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease. Alimentary pharmacology & therapeutics 59 (10) (2024)
Richard K Sterling, Eduardo Vilar-Gomez, Laura A Wilson ScM, Stephen Caldwell, Samer Gawrieh, Jennifer Price, Susanna Naggie, Jordan E Lake, Sonya L Heath, James Tonascia, Mark S Sulkowski, Naga Chalasani, null null
Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease. The American journal of gastroenterology 119 (8) (2024)
Nabil Noureddin, Daniel Q Huang, Ricki Bettencourt, Harris Siddiqi, Abdul M Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Hirokazu Takahashi, Ramazan Idilman, Mesut Gumussoy, Digdem Kuru Oz, Ayse Erden, Tolga Gidener, Alina M Allen, Veeral Ajmera, Stephen Caldwell
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease. Alimentary pharmacology & therapeutics 59 (12) (2024)
Nabil Noureddin, Daniel Q Huang, Ricki Bettencourt, Harris Siddiqi, Abdul M Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Hirokazu Takahashi, Ramazan Idilman, Mesut Gumussoy, Digdem Kuru Oz, Ayse Erden, Tolga Gidener, Alina M Allen, Veeral Ajmera, Stephen Caldwell
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease. Alimentary pharmacology & therapeutics (2024)
Richard K Sterling, Eduardo Vilar-Gomez, Laura A Wilson ScM, Stephen Caldwell, Samer Gawrieh, Jennifer Price, Susanna Naggie, Jordan E Lake, Sonya L Heath, James Tonascia, Mark S Sulkowski, Naga Chalasani, null null
Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease. The American journal of gastroenterology 119 (8) (2024)
Raj K Vuppalanchi, Stephen Caldwell, Arun J Sanyal, Amir Nikooie, Yuanyuan Tang, Deborah A Robins, Bram Brouwers, Mark L Hartman
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures. Alimentary pharmacology & therapeutics 60 (1) (2024)
Gauree G Konijeti, Stephen Caldwell
Response to Tapper and Chhatwal. The American journal of gastroenterology 119 (6) (2024)
Richard K Sterling, Eduardo Vilar-Gomez, Laura A Wilson ScM, Stephen Caldwell, Samer Gawrieh, Jennifer Price, Susanna Naggie, Jordan E Lake, Sonya L Heath, James Tonascia, Mark S Sulkowski, Naga Chalasani, null null
Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living with HIV and Steatotic Liver Disease. The American journal of gastroenterology (2024)
Gauree G Konijeti, Stephen Caldwell
Response to Tapper and Chhatwal. The American journal of gastroenterology 119 (6) (2024)
Gauree G Konijeti, Stephen Caldwell
Response to Tapper and Chhatwal. The American journal of gastroenterology 119 (6) (2024)
Naga P Chalasani, Eduardo Vilar-Gomez, Stephen Caldwell, Katherine P Yates, Anna Mae Diehl, Brent A Neuschwander-Tetri, Srinivasan Dasarathy, Kris V Kowdley, Norah A Terrault, Laura A Wilson, James Tonascia, Arun J Sanyal
PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease. Hepatology (Baltimore, Md.) (2024)
Lana Bridi, Saaket Agrawal, Kaleb Tesfai, Egbert Madamba, Ricki Bettencourt, Lisa M Richards, Amit V Khera, Stephen Caldwell, Veeral H Ajmera
The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. Alimentary pharmacology & therapeutics 60 (3) (2024)
Niharika R Samala, Yuchen Xin, Laura A Wilson ScM, Katherine P Yates, Stephen Caldwell, Jay H Hoofnagle, Naga Chalasani, null null
Non-Hispanic Black Persons With Nonalcoholic Fatty Liver Disease Have Lower Rates of Advanced Fibrosis, Cirrhosis, and Liver-Related Events Even After Controlling for Clinical Risk Factors and PNPLA3 Genotype. The American journal of gastroenterology (2024)
A Sidney Barritt, Feng Yu, Andrea R Mospan, Philip Noel Newsome, Michael Roden, Heather Lynne Morris, Stephen Caldwell, Brent A Neuschwander-Tetri, null null
High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort. The American journal of gastroenterology (2024)
Carolina A Ramírez, Hanna L Blaney, Natalia Kubanek, Luis Antonio Diaz, Stephen Caldwell, Lubomir Skladany, Juan Pablo Arab
Review article: Current indications and selection criteria for early liver transplantation in severe alcohol-associated hepatitis. Alimentary pharmacology & therapeutics 59 (9) (2024)
Cynthia Li-Shin Hsu, Stephen Caldwell
From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research. Nature metabolism 6 (4) (2024)
Elliot B Tapper, David S Goldberg, Neehar D Parikh, Norah A Terrault, Nicole Welch, Suzanne Sharpton, Bilal Hameed, Mandana Khalili, Andrew A Stolz, Elizabeth C Verna, Robert S Brown, Arun J Sanyal, Lisa B Van Wagner, Daniela P Ladner, Cynthia A Moylan, Anna Mae Diehl, Patricia D Jones, Stephen Caldwell, Srinivasan Dasarathy, Douglas A Simonetto, Vijay H Shah, Jasmohan Singh Bajaj, null null
The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints. The American journal of gastroenterology (2024)
Niharika R Samala, Yuchen Xin, Laura A Wilson ScM, Katherine P Yates, Stephen Caldwell, Jay H Hoofnagle, Naga Chalasani, null null
Non-Hispanic Black persons with nonalcoholic fatty liver disease have lower rates of advanced fibrosis, cirrhosis, and liver-related events even after controlling for clinical risk factors and PNPLA3 genotype. The American journal of gastroenterology (2024)
Theodore T Pierce, Arinc Ozturk, Sarah P Sherlock, Guilherme Moura Cunha, Xiaohong Wang, Qian Li, David Hunt, Michael S Middleton, Marian Martin, Kathleen E Corey, Hannah Edenbaum, Sudha S Shankar, Helen Heymann, Tania N Kamphaus, Roberto A Calle, Yesenia Covarrubias, Stephen Caldwell, Nancy A Obuchowski, Arun J Sanyal, Claude B Sirlin, Kathryn J Fowler, Anthony E Samir
Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease. Radiology 312 (3) (2024)
Stephen Caldwell, Ginger Clark, Jeff Teckman, Veeral H Ajmera, Cynthia Behling, Mark Brantly, David Brenner, Jeanine D'Armiento, Michael W Fried, Janani S Iyer, Mattias Mandorfer, Don C Rockey, Monica A Tincopa, Raj K Vuppalanchi, Zobair M Younossi, Aleksander Krag, Alice M Turner, Pavel Strnad
Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease. Alimentary pharmacology & therapeutics (2024)
Benjamin Koh, Jieling Xiao, Cheng Han Ng, Michelle Law, Shyna Zhuoying Gunalan, Pojsakorn Danpanichkul, Vijay Ramadoss, Benedix Kuan Loon Sim, En Ying Tan, Chong Boon Teo, Benjamin Nah, Margaret Teng, Karn Wijarnpreecha, Yuya Seko, Mei Chin Lim, Hirokazu Takahashi, Atsushi Nakajima, Mazen Noureddin, Mark Muthiah, Daniel Q Huang, Stephen Caldwell
Comparative efficacy of pharmacologic therapies for MASH in reducing liver fat content: Systematic review and network meta-analysis. Hepatology (Baltimore, Md.) (2024)
Wen Hui Lim, Phoebe Tay, Cheng-Han Ng, Darren Jun Hao Tan, Christen Ong, Jia Hong Koh, Margaret Teng, Douglas Chee, Zhen Yu Wong, Takumi Kawaguchi, Hirokazu Takahashi, Mark Dhinesh Muthiah, Eunice X X Tan, Karn Wijarnpreecha, Guan Huei Lee, Mazen Noureddin, Brian P Lee, Philippe Mathurin, Stephen Caldwell, Daniel Q Huang
Meta-analysis: Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis. Alimentary pharmacology & therapeutics 59 (6) (2024)
Cynthia Li-Shin Hsu, Stephen Caldwell
From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research. Nature metabolism (2024)
Nabil Noureddin, Nedret Copur-Dahi, Stephen Caldwell
Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease. Alimentary pharmacology & therapeutics (2024)
Maria C Rieman-Klingler, Jinho Jung, Kaleb Tesfai, Stephen Caldwell, Amy L Non
Integrating genetic and socioeconomic data to predict the progression of nonalcoholic fatty liver disease. American journal of biological anthropology 184 (4) (2024)
Jiating Huang, Hu Lin, A-Na Liu, Wei Wu, Anna Alisi, Stephen Caldwell, Cuifang Xu, Wenqin Xiang, Jie Shao, Guanping Dong, Ming-Hua Zheng, Junfen Fu, Yan Ni
Dynamic pattern of postprandial bile acids in paediatric non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver (2024)
Maria C Rieman-Klingler, Jinho Jung, Kaleb Tesfai, Stephen Caldwell, Amy L Non
Integrating genetic and socioeconomic data to predict the progression of nonalcoholic fatty liver disease. American journal of biological anthropology 184 (4) (2024)
Stephen Caldwell, Mark L Hartman, Eric J Lawitz, Raj Vuppalanchi, Jérôme Boursier, Elisabetta Bugianesi, Masato Yoneda, Cynthia Behling, Oscar W Cummings, Yuanyuan Tang, Bram Brouwers, Deborah A Robins, Amir Nikooie, Mathijs C Bunck, Axel Haupt, Arun J Sanyal, null null
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis. The New England journal of medicine 391 (4) (2024)
Niharika R Samala, Yuchen Xin, Laura A Wilson ScM, Katherine P Yates, Stephen Caldwell, Jay H Hoofnagle, Naga Chalasani, null null
Non-Hispanic Black persons with nonalcoholic fatty liver disease have lower rates of advanced fibrosis, cirrhosis, and liver-related events even after controlling for clinical risk factors and PNPLA3 genotype. The American journal of gastroenterology (2024)
Carolin Victoria Schneider, Kai Markus Schneider, Stephen Caldwell
Editorial: Crystalising the burden of steatotic liver disease-Authors' reply. Alimentary pharmacology & therapeutics 59 (10) (2024)
Niharika R Samala, Yuchen Xin, Laura A Wilson ScM, Katherine P Yates, Stephen Caldwell, Jay H Hoofnagle, Naga Chalasani, null null
Non-Hispanic Black Persons With Nonalcoholic Fatty Liver Disease Have Lower Rates of Advanced Fibrosis, Cirrhosis, and Liver-Related Events Even After Controlling for Clinical Risk Factors and PNPLA3 Genotype. The American journal of gastroenterology (2024)
Stephen Caldwell, Alnoor Ramji, Tarek Hassanein, Eric M Yoshida, Emily Pang, Caitlin Schneider, Michael P Curry, Nezam H Afdhal
Velacur ACE outperforms FibroScan CAP for diagnosis of MASLD. Hepatology communications 8 (4) (2024)
Niharika R Samala, Yuchen Xin, Laura A Wilson ScM, Katherine P Yates, Stephen Caldwell, Jay H Hoofnagle, Naga Chalasani, null null
Non-Hispanic Black persons with nonalcoholic fatty liver disease have lower rates of advanced fibrosis, cirrhosis, and liver-related events even after controlling for clinical risk factors and PNPLA3 genotype. The American journal of gastroenterology (2024)
Richard K Sterling, Eduardo Vilar-Gomez, Laura A Wilson ScM, Stephen Caldwell, Samer Gawrieh, Jennifer Price, Susanna Naggie, Jordan E Lake, Sonya L Heath, James Tonascia, Mark S Sulkowski, Naga Chalasani, null null
Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease. The American journal of gastroenterology (2024)
Suzanne R Sharpton, Stephen Caldwell
Reply: Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC. Hepatology (Baltimore, Md.) (2024)
Cynthia Li-Shin Hsu, Stephen Caldwell
From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research. Nature metabolism 6 (4) (2024)
Cynthia Li-Shin Hsu, Stephen Caldwell
From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research. Nature metabolism 6 (4) (2024)
Wen Hui Lim, Phoebe Tay, Cheng-Han Ng, Darren Jun Hao Tan, Christen Ong, Jia Hong Koh, Margaret Teng, Douglas Chee, Zhen Yu Wong, Takumi Kawaguchi, Hirokazu Takahashi, Mark Dhinesh Muthiah, Eunice X X Tan, Karn Wijarnpreecha, Guan Huei Lee, Mazen Noureddin, Brian P Lee, Philippe Mathurin, Stephen Caldwell, Daniel Q Huang
Meta-analysis: Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis. Alimentary pharmacology & therapeutics 59 (6) (2024)
Nabil Noureddin, Nedret Copur-Dahi, Stephen Caldwell
Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease. Alimentary pharmacology & therapeutics (2024)
Carolin Victoria Schneider, Kai Markus Schneider, Anastasia Raptis, Helen Huang, Christian Trautwein, Stephen Caldwell
Prevalence of at-risk MASH, MetALD and alcohol-associated steatotic liver disease in the general population. Alimentary pharmacology & therapeutics 59 (10) (2024)
Carolin Victoria Schneider, Kai Markus Schneider, Anastasia Raptis, Helen Huang, Christian Trautwein, Stephen Caldwell
Prevalence of at-risk MASH, MetALD and alcohol-associated steatotic liver disease in the general population. Alimentary pharmacology & therapeutics (2024)
Wen Hui Lim, Phoebe Tay, Cheng-Han Ng, Darren Jun Hao Tan, Christen Ong, Jia Hong Koh, Margaret Teng, Douglas Chee, Zhen Yu Wong, Takumi Kawaguchi, Hirokazu Takahashi, Mark Dhinesh Muthiah, Eunice X X Tan, Karn Wijarnpreecha, Guan Huei Lee, Mazen Noureddin, Brian P Lee, Philippe Mathurin, Stephen Caldwell, Daniel Q Huang
Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis: Systematic review and meta-analysis. Alimentary pharmacology & therapeutics (2024)
Daniel Q Huang, Laura A Wilson, Cynthia Behling, Maral Amangurbanova, David E Kleiner, Kris V Kowdley, Srinivasan Dasarathy, Norah A Terrault, Anna Mae Diehl, Naga Chalasani, Brent A Neuschwander-Tetri, Arun J Sanyal, James Tonascia, Stephen Caldwell, null null
Liver stiffness progression in biopsy-proven metabolic dysfunction-associated steatotic disease among people with diabetes versus people without diabetes: A prospective multicenter study. Hepatology (Baltimore, Md.) (2024)
Richard K Sterling, Eduardo Vilar-Gomez, Laura A Wilson ScM, Stephen Caldwell, Samer Gawrieh, Jennifer Price, Susanna Naggie, Jordan E Lake, Sonya L Heath, James Tonascia, Mark S Sulkowski, Naga Chalasani, null null
Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease. The American journal of gastroenterology 119 (8) (2024)
Raj K Vuppalanchi, Stephen Caldwell, Arun J Sanyal, Amir Nikooie, Yuanyuan Tang, Deborah A Robins, Bram Brouwers, Mark L Hartman
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures. Alimentary pharmacology & therapeutics 60 (1) (2024)
Wen Hui Lim, Phoebe Tay, Cheng-Han Ng, Darren Jun Hao Tan, Christen Ong, Jia Hong Koh, Margaret Teng, Douglas Chee, Zhen Yu Wong, Takumi Kawaguchi, Hirokazu Takahashi, Mark Dhinesh Muthiah, Eunice X X Tan, Karn Wijarnpreecha, Guan Huei Lee, Mazen Noureddin, Brian P Lee, Philippe Mathurin, Stephen Caldwell, Daniel Q Huang
Prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis: Systematic review and meta-analysis. Alimentary pharmacology & therapeutics (2024)
Nabil Noureddin, Nedret Copur-Dahi, Stephen Caldwell
Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease. Alimentary pharmacology & therapeutics (2024)
Fasiha Kanwal, Brent A Neuschwander-Tetri, Stephen Caldwell, Mary E Rinella
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.) (2023)
Ashwini Mulgaonkar, Daniel Q Huang, Harris Siddiqi, Kathryn J Fowler, Claude B Sirlin, Robert Marks, Stephen Caldwell, Gauree Gupta Konijeti
Cost-Effectiveness Analysis of Hepatocellular Carcinoma Surveillance in Nonalcoholic Fatty Liver Disease Cirrhosis Using US Visualization Score C-Triggered Abbreviated MRI. The American journal of gastroenterology 119 (7) (2023)
Arun J Sanyal, Sudha Shankar, Katherine Yates, James Bolognese, Erica Daly, Clayton Dehn, Brent A Neuschwander-Tetri, Kris Kowdley, Raj Vuppalanchi, Cynthia A Behling, James Tonascia, Anthony Samir, Claude B Sirlin, Sarah Sherlock, Kathryn Fowler, Helen Heymann, Tania Kamphaus, Stephen Caldwell, Roberto A Calle
The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis. Research square (2023)
Stephen Caldwell, Vincent Wai-Sun Wong
Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease. Alimentary pharmacology & therapeutics 59 (2) (2023)
Daniel Q Huang, Norah A Terrault, Frank Tacke, Lise Lotte Gluud, Marco Arrese, Elisabetta Bugianesi, Stephen Caldwell
Global epidemiology of cirrhosis - aetiology, trends and predictions. Nature reviews. Gastroenterology & hepatology (2023)
Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, Jordan E Lake, Laura A Wilson, Jennifer C Price, Susanna Naggie, Richard K Sterling, Sonya Heath, Kathleen E Corey, Edward R Cachay, Veeral Ajmera, James Tonascia, Mark S Sulkowski, Naga P Chalasani, Stephen Caldwell
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Alimentary pharmacology & therapeutics 59 (5) (2023)
A-Na Liu, Cui-Fang Xu, Ya-Ru Liu, Dan-Qin Sun, Ling Jiang, Liang-Jie Tang, Pei-Wu Zhu, Sui-Dan Chen, Wen-Yue Liu, Xiao-Dong Wang, Giovanni Targher, Christopher D Byrne, Vincent Wai-Sun Wong, Junfen Fu, Ming-Ming Su, Stephen Caldwell, Ming-Hua Zheng, Yan Ni
Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease. Alimentary pharmacology & therapeutics (2023)
Samer Gawrieh, Eduardo Vilar-Gomez, Tinsay A Woreta, Jordan E Lake, Laura A Wilson, Jennifer C Price, Susanna Naggie, Richard K Sterling, Sonya Heath, Kathleen E Corey, Edward R Cachay, Veeral Ajmera, James Tonascia, Mark S Sulkowski, Naga P Chalasani, Stephen Caldwell
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Alimentary pharmacology & therapeutics 59 (5) (2023)
Selena Z Kuo, Stephen Caldwell
Letter: Are we forgetting the importance of steatosis in steatotic liver disease? Authors' reply. Alimentary pharmacology & therapeutics 59 (2) (2023)
Nabil Noureddin, Veeral H Ajmera, Jaclyn Bergstrom, Richele Bettencourt, Daniel Q Huang, Harris Siddiqi, Abdul M Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Hirokazu Takahashi, Ramzan Idilman, Mesut Gumussoy, Digdem Kuru Oz, Ayse Erden, Stephen Caldwell
MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-analyses. Alimentary pharmacology & therapeutics (2023)

Stephen Caldwell.css-eqlu8i{font-size:small;padding-left:4px;} (Rohit Loomba, R Loomba, Rohit C Loomba)

Publication Activity (10 Years)

Top Topics

Top Venues

Stephen Caldwell (Rohit Loomba, R Loomba, Rohit C Loomba)